世界級科學家菁英薈萃～《2021台灣國際創新生物醫學峰會》在中國醫藥大學舉行

(中央社訊息服務20211119 14:36:34)世界級科學家菁英薈萃～《2021台灣國際創新生物醫學峰會》在中國醫藥大學舉行

《2021台灣國際創新生物醫學峰會》11月19日上午在中國醫藥大學水湳校區國際會議廳舉行開幕式，全程以英文進行，前副總統陳建仁院士透過視訊致賀並發表演講，美國哈佛大學的諾貝爾獎得主William G.Kaelin等16位國內外癌症領域的頂尖學者擔任大會主題演講嘉賓，蔡長海董事長誠摰歡迎國內外癌症領域的頂尖學者蒞會，促進台灣國際合作和生物醫學科學發展；洪明奇校長期待透過舉辦大型國際學術研討會，提昇我國生物醫學研究在國際研究圈的地位，將台灣創新生物醫學研究與技術推向國際舞台。

中國醫藥大學暨醫療身體系董事長蔡長海博士致詞表示，《2021台灣國際創新生物醫學峰會》為學生和青年科學家提供了一個吸收新知識、跟上世界步伐、勇於創新和創造的絕佳機會，正如我一直鼓勵學生掌握世界潮流，成為全球領導者。

近年來，中國醫藥大學和附設醫院大力推進基礎科研和轉譯醫學的研究，以發展針對人類最大敵人癌症的精準創新療法。為此，我們一直在全球範圍內招募頂尖研究人員/醫生，與國內外機構合作，並舉辦 ICABS及其類似的國際會議。

蔡長海董事長衷心感謝所有國際國內專家對此次有意義的盛會的付出，由於COVID-19大流行，國際演講者無法親自出席會議，透過視訊參加大會，期待日後有機會來台灣分享研究經驗與交流。

中國醫藥大學校長洪明奇院士致詞表示，近年來台灣的生物醫學研究成果，不論在質與量上都有空前的進步。然而，在生物醫學各領域之間的研究，存在著許多的關聯與互需性，且各領域間研究的藩籬正快速地消退，各領域間的互動與結合日益迫切。

為此，中國醫藥大學舉辦此次大型國際學術研討會在促進彼此合作的過程中扮演很重要的角色，邀請到十幾位美國、日本和台灣院士級的頂尖專家學者與會討論與交流，並以癌症醫學為中心主軸，串聯生物醫學各領域連結成一個密切相關的生物醫學科學網，共同探討癌症的難題，為人類的健康謀最大的福祉。另外，邀請台灣近期俱優秀表現的學者作研究亮點分享，希望展現台灣的研究實力，讓台灣在生命科學的成果也能被世界所看見。

洪明奇校長說，中國醫藥大學將此國際研討會每年都在台中水湳校區舉辦，以促進台灣在生醫及生科領域的國際地位。

亞洲大學校長蔡進發博士致詞表示，亞大研究團隊利用人工智能、AI機器學習和生物醫學數據科學，推動癌症相關研究，以提高生存率和創新的癌症療法；同時利用大數據評估慢性病患者的心血管風險腎臟疾病，這些研究和眾多成功案例，幫助解決現實世界中的問題，改善健康生活，並促進所有人的福祉。

前副總統陳建仁院士在肝炎防治的公衞研究上的貢獻著越，他在專題演講總結臺灣肝炎研究，闡述對於肝炎防治及肝癌的預防有重要意義。

美國哈佛大學的William G. Kaelin教授是2019年諾貝爾生理醫學獎得主，他透過視訊講述癌細胞在缺氧環境下成為更為惡性的機轉及抗癌藥物研發，目前其已開發出一款臨床新薬，由美國藥物食品檢驗局核准。

由中國醫藥大學校長洪明奇院士創辦的《2021台灣國際創新生物醫學峰會》International Conference on Advanced Biomedical Sciences,Taiwan，於11月19-21日在中國醫藥大學水湳校區國際會議廳舉行三天，邀請到國內外癌症領域的頂尖學者，包括17位美國科學院院士，其中Drs William Kaelin，Randy Schekman為諾貝爾獎得主，前副總統陳建仁(Chien-Jen Chen)院士，Tony Hunter (唐獎得主)，Lewis Cantley，Irving Weissman，Zhijian James Chen，Dinshaw Patel，2021威爾許化學獎得主Chi-Huey Wong (翁啟惠)，Ron DePinho；國際癌症頂尖學者有Zhimin (James) Lu，Xiang-Dong Fu，Dihua Yu，Wenyi Wei，Nagahiro Minato(日本京都大學校長)；國內重量級學者陳建仁院士(Chien-Jen Chen), Chi-Huey Wong (翁啟惠)院士，楊泮池院士(Pan-Chyr Yang),洪明奇院士(Mien-Chie Hung)；演題涵蓋了當前國內外最重要也最具前瞻性的生物醫學議題：包括癌症訊息傳遞(Signal Transduction and Cancer)、癌症代謝(Cancer Metabolism)、幹細胞(Stem Cells)、癌症免疫(Cancer Immunology)、創新技術與轉譯（Novel technology and translational innovation）、新穎癌症治療(Innovative Cancer Therapy)等六大主要議題進行最新研究成果的分享與交流。

在醫學峰會會場還展出全台各生醫相關領域研究單位及大專院校優秀的碩博士班學生及博士後學者投稿壁報論文摘要，讓台灣生物醫學的研究成果能被世界所看見，吸引600餘人參與盛會。

蔡長董事長致詞全文如下：
Good evening Dr. Kaelin and Dr. Schekmen. Thank you very much for joining us from US.

Academician Whang-Peng, Academician Wu, Academician Yu (彭汪嘉康,吳成文,陳鈴津院士) President Hung, President Tsai, Superintendent Cho…….. distinguished guests and scientists from Taiwan, colleagues and students from CMU health care system, Good Morning!

It is my great pleasure to welcoming you to attend the first ICABS (International Conference on Advanced Biomedical Sciences) conference in CMU Shuinan new campus. This is the first international conference in this campus since we moved here a year ago. Thanks to President Hung’s vision in creating this ICABS, which will occur every year. This annual international conference has full support from the CMU Board of Trustees, and I look forward to its impact on the promotion of international collaboration and biomedical sciences in Taiwan.

China Medical University and hospitals stride to promote both fundamental and translational researches for the development of precise and innovative therapy against cancer, which is human’s biggest enemy. To do so, we have been recruiting top researchers/physicians worldwide, collaborating with domestic and international institutions, and organizing international conferences such as ICABS.

This conference provides an excellent opportunity for students and young scientists to absorb new knowledge, keep up with the pace of the world, and to be innovative and creative. As I always encourage students to master the trends of the world and become the global leader.

Finally, I would like to express my sincere gratitude to all international and domestic experts for your commitment to this meaningful event. It is a pity due to the COVID-19 pandemic the international speakers could not attend the conference in person. But I believe there will be many other opportunities for you to visit Taiwan. I wish the great success of the conference. Thank you!!

洪明奇校長致詞全文如下：

Chairman Tsai, all my friends, academicians from Academia Sinica, and our keynote speakers my dear friends, Dr. Bill Kaelin and Dr. Randy Schekmen on line,林昭庚董事,黃冠棠董事, 鄭隆賓執行長, Asia Univ. President, Tsai, and All Vice Presidents of CMU, and, our hospital, Superintendent 周, also my Colleagues and Friends from all over Taiwan , and ladies and gentlemen: Good morning and good afternoon (Randy) or good Evening (Bill):

On behalf of Organizing Committee, I am extremely pleased to welcome all of you to attend the inaugural International Conference on Advanced Biomedical Sciences (ICABS) to be held at the new Shuei Nan campus of China Medical University in Taichung. Welcome!
This inaugural conference aims to serve as a bridge between international experts and domestic talents in Taiwan to promote biomedical sciences in Taiwan and also contribute to the world. We plan to make this conference an annual event and attract participants from worldwide. In fact, the ICABS 2022 is under preparation. 在座的國內的專家學者老師以及學生，這個國際創新生物醫學會議以後每年在水湳都會舉行一次，所以記得明天繼續來參加。

As you can see from the agenda, We have invited myriad international renowned speakers from the world and Taiwan to inaugurate the 2021 ICABS conference. Our speakers include Nobel Laureates, Members of US National Academy of Sciences, Academicians of Academia Sinica, and prominent speakers from US, Japan and China in addition to Taiwan. Besides keynote speeches, the conference has 6 sessions focusing on current trends in biomedical sciences, especially cancer biology such as Signal Transduction and Cancer, Cancer Metabolism, Stem Cell, Cancer Immunology, Novel Technology and Translational Innovation, and Innovative Cancer Therapy. It is worthwhile to mention that each session will be moderated by a highly well-respected scientist from Taiwan. The original plan was to have concurrent Meet-the-Expert luncheons with all invited speakers to give opportunity of local scientists including graduate students and postdoc fellows to meet with world experts face-to-face. Due to Covid-19 pandemic, our international speakers cannot join in person so, we cannot run the meet-the-expert luncheons program this year. However, luckily, all our speakers agree to join either on line or in person. I greatly appreciate all the speakers’ efforts to make this conference possible. There are almost 500 people registered to join this conference up to yesterday, mainly from Taiwan. Since we just moved into this new campus about one year ago, we would very much like to invite local scientists to take this opportunity to visit our new campus. So we do not really open for on line participation for local people, except for the international speakers. We certainly wish to make this annual ICABS conference become an annual scientific conference in Taiwan. In the future, we will make sure running the meet-the -expert program to allow world experts meeting with their fans! And may also consider to open for on line participations.

Lastly, I would like take this opportunity to thank for the generous support from the Ministry of Science and Technology, Chairman Tsai and the entire Board of Trustee of China Med University, colleagues from China Medical University and Health Care System and also our Sister University, Asia university. I also like to thanks our friends, Academicians of Academia Sinica , experts in Taiwan, the organization committee for the 1.5 years planning and our staffs for all the logistic supports. Or course, importantly, all participants in the audience. With your support, trust we will have a successful conference these two days. I am really looking forward to it!

Randy and Bill,
Sorry, you cannot join in person this time, but we certainly appreciate your participating this opening ceremony and welcome you to visit us whenever you can. Randy, I will probably see you again soon through on line in the Tang Prize committee. And Bill, hope to see you in the Breast Cancer Research Foundation (BCRF) with Larry Norton in NYC next Oct. Btw, would you like to say “Hi” to the audience? Or say a few words to your fans!